Association of the quality of life parameters with the indicators of chronic heart failure severity in patients with rheumatoid arthritis

Cover Page

Cite item

Full Text

Abstract

Background: The quality of life of patients is one of determining factors in assessing the effectiveness of treatment and prognosis. A search for possible associations of the quality of life parameters with basic clinical indicators provides a possibility of a more detailed and comprehensive assessment of the patient’s condition, correction of therapy and an improvement in the prognosis. Aim: To carry out a comparative analysis of the quality of life parameters in patients with chronic heart failure (CHF) with preserved and moderately reduced left ventricular ejection fraction against the background of rheumatoid arthritis (RA) and without RA, as well as to identify possible associations of the quality of life indicators with the parameters of the CHF course. Methods: 134 CHF patients with an RA diagnosis were examined, as well as 122 CHF patients without RA. The functional class of CHF in patients participated in the study was I -II by NYHA. The diagnosis of RA was made on the basis of radiological and serological studies. The radiological stage of RA in patients included in the study was I -III, according to Steinbrocker. Methotrexate was the basic anti-inflammatory drug for the RA treatment. A comparative analysis of the CHF symptoms, morphofunctional parameters and their possible association with the quality of life indicators in patients with and without RA was performed. The processing was carried out using the Statistica 10.0 program. Results: In the group of patients with CHF and RA, in addition to the statistically significant differences in the standard clinical laboratory parameters, statistically significant differences were also revealed in the severity of pain syndrome, deterioration of role, physical and emotional functioning as compared to the CHF patients without RA. Besides, in the CHF/RA group, statistically significant associations were revealed between the severity of pain syndrome and the level of the left ventricular ejection fraction and left ventricular mass index. Conclusion: The severity of pain syndrome caused by RA in patients with CHF can negatively affect some morphological and functional parameters of the myocardium, which must be taken into account when managing this group of patients.

About the authors

Andrey S. Ankudinov

Irkutsk State Medical University

Author for correspondence.
Email: andruhin.box@ya.ru
ORCID iD: 0000-0002-5188-7997

MD, PhD, Professor

Russian Federation, Irkutsk

Alexey N. Kalyagin

Irkutsk Medical State University

Email: akalagin@yandex.ru
ORCID iD: 0000-0002-2708-3972

MD, PhD, Professor

Russian Federation, Irkutsk

References

  1. Shoemaker MJ, Dias KJ, Lefebvre KM, et al. Physical therapist clinical practice guideline for the management of individuals with heart failure. Physical Therapy. 2020;100(1):114–143. doi: 10.1093/ptj/pzz127
  2. Aune D, Schlesinger S, Leitzmann MF, et al. Physical activity and the risk of heart failure: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2021;36(4):367–381. doi: 10.1007/s10654-020-00693-6
  3. Osthoff R, Niedermann K, Braun J, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheumatic Dis. 2018; 77(9):1251–1260. doi: 10.1136/annrheumdis-2018-213585
  4. Metsios GS, Kitas GD. Physical activity, exercise and rheumatoid arthritis: Effectiveness, mechanisms and implementation. Best Pract Res Clin Rheumatol. 2018;32(5):669–682. doi: 10.1016/j.berh.2019.03.013
  5. Haedtke C, Smith M, Buren VJ, et al. The characteristics of pain in patients diagnosed with depression and heart failure. Pain Management Nursing. 2017;18(6):353–362. doi: 10.1016/j.pmn.2017.05.005
  6. Haedtke C, Smith M, Buren VJ, et al. The relationships among pain, depression, and physical activity in patients with heart failure. J Cardiovascular Nur. 2017;32(5):21–25. doi: 10.1097/JCN.0000000000000399
  7. Ueno K, Kamiya K, Hamazaki N, et al. Usefulness of physical function sub-item of SF-36 survey to predict exercise intolerance in patients with heart failure. Eur J Cardiovascular Nur. 2021;(29): zvab052. doi: 10.1093/eurjcn/zvab052
  8. Клинические рекомендации: хроническая сердечная недостаточность. Российское кардиологическое общество. Национальное общество по изучению сердечной недостаточности и заболеваний миокарда. 2020. [Clinical recommendations: chronic heart failure. Russian Society of Cardiology. National Society for the Study of Heart Failure and Myocardial Diseases. 2020. (In Russ).] Режим доступа: http://cr.rosminzdrav.ru/schema/156. Дата обращения: 17.12.2021.
  9. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368
  10. Насонов ЕЛ. Ревматология. Клинические рекомендации. Москва: ГЭОТАР-Медиа, 2017. 464 с. [Nasonov EL. Rheumatology. Clinical recommendations. Moscow: GEOTAR-Media; 2017. 464 p. (In Russ).]
  11. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. Москва: МедиаСфера, 2002. 312 с. [Rebrova OY. Statistical analysis of medical data. Application of the STATISTICA application software package. Moscow: MediaSphere; 2002. 312 p. (In Russ).]
  12. Абдарахманова А.И., Зарипова Ф.А., Амиров Н.Б. Расстройства тревожно-депрессивного спектра при ревматических заболеваниях // Вестник современной клинической медицины. 2020. Т. 13, № 1. С. 61–65. [Abdarahmanova AI, Zaripova FA, Amirov NB. Disorders of the anxiety-depressive spectrum in rheumatic diseases. Bulletin Modern Clin Med. 2020;13(1):61–65. (In Russ).]
  13. Ефремова Е.Ф., Шутов А.М., Бородулина Е.О. Проблема коморбидности при хронической сердечной недостаточности // Ульяновский медико-биологический журнал. 2015. № 4. С. 46–52. [Efremova EF, Shutov AM, Borodulina EO. The problem of comorbidity in chronic heart failure. Ulyanovsk Med Biol J. 2015; 4:46–52. (In Russ).]
  14. Hollan I, Ronda N, Dessein P, et al. Lipid management in rheumatoid arthritis: a position paper by the cardiovascular pharmacotherapy working group of European society of cardiology. E Heart J Cardiovascular Pharmacotherapy. 2019;(6): 104–114. doi: 10.1093/ehjcvp/pvz033
  15. Drosos GC, Vedder D, Houben E, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheumatic Dis. 2022; 81(6):768–779. doi: 10.1136/annrheumdis-2021-221733
  16. Logstrup BB, Masic D, Laurbjerg TB, et al. Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study. Scand J Rheumatol. 2017;46(6):432–440. doi: 10.1080/03009742.2016.1249941
  17. Nguyen TH, Fagerland MW, Deyab G, et al. Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis. PLoS ONE. 2021;16(6):e0253793. doi: 10.1371/journal.pone.0253793
  18. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Comparative analysis of the parameters of the quality of life in the surveyed groups, %.

Download (929KB)

Copyright (c) 2022 Ankudinov A.S., Kalyagin A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies